Home > Products > CD28 & CD3
> Anti-CD28 x Anti-CD3 Bispecific Antibody (IgG-IgG)
Anti-CD28 x Anti-CD3 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-054)
Anti-CD28 x Anti-CD3 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD28 and anti-CD3 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can improve T-cell activation. It is designed for the research of Tumors therapy.
There are currently no customer reviews or questions for Anti-CD28 x Anti-CD3 Bispecific Antibody (IgG-IgG) (BSIG-054). Click the button below to contact us or submit your feedback about this product.